Sayuri Yamazaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Sayuri Yamazaki has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Masaki Imai
Department of Immunology Nagoya City University Graduate School of Medical Sciences Nagoya Japan
8 shared publications- Akimichi Morita
Department of Geriatric and Environmental Dermatology Nagoya City University Graduate School of Medical Sciences Nagoya Japan
7 shared publications - Hiroaki Shime
Department of Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
7 shared publications Mizuyu Odanaka
Department of Immunology Nagoya City University Graduate School of Medical Sciences Nagoya Japan
7 shared publicationsNaganari Ohkura
Department of Experimental Immunology, World Premier International Research Center Initiative, Immunology Frontier Research Center Osaka University Osaka Japan
6 shared publicationsShimon Sakaguchi
Department of Experimental Immunology, World Premier International Research Center Initiative, Immunology Frontier Research Center Osaka University Osaka Japan
6 shared publications
Latest Publications
- Open Access
- 24 December 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (7) , 1770-1780.e11
UVB Irradiation Expands Skin-Resident CD81+Foxp3+ Regulatory T Cells with a Highly Activated Phenotype
- 24 December 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (7) , 1770-1780.e11
Open AccessUVB Irradiation Expands Skin-Resident CD81+Foxp3+ Regulatory T Cells with a Highly Activated Phenotype
- Open Access
- 2 July 2024
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 37 (1) , 5-14
Diverse roles of dendritic cell and regulatory T cell crosstalk in controlling health and disease
Dendritic cells (DCs) are specialized antigen-presenting cells for lymphocytes, including regulatory T (Treg) cells, a subset of CD4+ T cells expressing CD25 and Foxp3, a transcription factor. Treg cells maintain immunological self-tolerance in mice and humans, and suppress autoimmunity and other various immune responses such as tumor immunity, transplant rejection, allergy, responses to microbes, and inflammation. Treg cell proliferation is controlled by antigen-presenting DCs. On the other hand, Treg cells suppress the function of DCs by restraining DC maturation. Therefore, the interaction between DCs and Treg cells, DC–Treg crosstalk, could contribute to controlling health and disease. We recently found that unique DC–Treg crosstalk plays a role in several conditions. First, Treg cells are expanded in ultraviolet-B (UVB)-exposed skin by interacting with DCs, and the UVB-expanded Treg cells have a healing function. Second, manipulating DC–Treg crosstalk can induce effective acquired immune responses against SARS-CoV2 antigens without adjuvants. Third, Treg cells with a special feature interact with DCs in the tumor microenvironment of human head and neck squamous cell cancer, which may contribute to the prognosis. Understanding the underlying mechanisms of DC–Treg crosstalk may provide a novel strategy to control health and disease.
- 2 July 2024
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 37 (1) , 5-14
Open AccessDiverse roles of dendritic cell and regulatory T cell crosstalk in controlling health and disease
Dendritic cells (DCs) are specialized antigen-presenting cells for lymphocytes, including regulatory T (Treg) cells, a subset of CD4+ T cells expressing CD25 and Foxp3, a transcription factor. Treg cells maintain immunological self-tolerance in mice and humans, and suppress autoimmunity and other various immune responses such as tumor immunity, transplant rejection, allergy, responses to microbes, and inflammation. Treg cell proliferation is controlled by antigen-presenting DCs. On the other hand, Treg cells suppress the function of DCs by restraining DC maturation. Therefore, the interaction between DCs and Treg cells, DC–Treg crosstalk, could contribute to controlling health and disease. We recently found that unique DC–Treg crosstalk plays a role in several conditions. First, Treg cells are expanded in ultraviolet-B (UVB)-exposed skin by interacting with DCs, and the UVB-expanded Treg cells have a healing function. Second, manipulating DC–Treg crosstalk can induce effective acquired immune responses against SARS-CoV2 antigens without adjuvants. Third, Treg cells with a special feature interact with DCs in the tumor microenvironment of human head and neck squamous cell cancer, which may contribute to the prognosis. Understanding the underlying mechanisms of DC–Treg crosstalk may provide a novel strategy to control health and disease.
- Open Access
- 23 January 2023
- Published by Wiley in Cancer Science
- Vol. 114 (4) , 1256-1269
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
We previously reported that regulatory T (Treg) cells expressing CTLA‐4 on the cell surface are abundant in head and neck squamous cell carcinoma (HNSCC). The role of expanded Treg cells in the tumor microenvironment of HNSCC remains unclear. In this study, we reveal that the tumor microenvironment of HNSCC is characterized by the high expression of genes related to Treg cells, dendritic cells (DCs), and interleukin (IL)‐17‐related molecules. Increased expression of IL17A, IL17F, or IL23A contributes to a favorable prognosis of HNSCC. In the tumor microenvironment of HNSCC, IL23A and IL12B are expressed in mature dendritic cells enriched in regulatory molecules (mregDCs). The mregDCs in HNSCC are a migratory and mature phenotype; their signature genes strongly correlate with Treg signature genes in HNSCC. We also observed that IL17A was highly expressed in Th17 cells and exhausted CD8+ T cells in HNSCC. These data suggest that mregDCs in HNSCC may contribute to the prognosis by balancing Treg cells and effector T cells that produce IL‐17. Targeting mregDCs may be a novel strategy for developing new immune therapies against HNSCC.
- 23 January 2023
- Published by Wiley in Cancer Science
- Vol. 114 (4) , 1256-1269
Open AccessMature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
We previously reported that regulatory T (Treg) cells expressing CTLA‐4 on the cell surface are abundant in head and neck squamous cell carcinoma (HNSCC). The role of expanded Treg cells in the tumor microenvironment of HNSCC remains unclear. In this study, we reveal that the tumor microenvironment of HNSCC is characterized by the high expression of genes related to Treg cells, dendritic cells (DCs), and interleukin (IL)‐17‐related molecules. Increased expression of IL17A, IL17F, or IL23A contributes to a favorable prognosis of HNSCC. In the tumor microenvironment of HNSCC, IL23A and IL12B are expressed in mature dendritic cells enriched in regulatory molecules (mregDCs). The mregDCs in HNSCC are a migratory and mature phenotype; their signature genes strongly correlate with Treg signature genes in HNSCC. We also observed that IL17A was highly expressed in Th17 cells and exhausted CD8+ T cells in HNSCC. These data suggest that mregDCs in HNSCC may contribute to the prognosis by balancing Treg cells and effector T cells that produce IL‐17. Targeting mregDCs may be a novel strategy for developing new immune therapies against HNSCC.
- Open Access
- 9 December 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (12) , e1010085
Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens
Regulatory T (Treg) cells, which constitute about 5–10% of CD4+T cells expressing Foxp3 transcription factor and CD25(IL-2 receptor α chain), are key regulators in controlling immunological self-tolerance and various immune responses. However, how Treg cells control antigen-specific immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unclear. In this study, we examined the effect of transient breakdown of the immunological tolerance induced by Treg-cell depletion on adaptive immune responses against administered SARS-CoV-2 antigen, spike protein 1 (S1). Notably, without the use of adjuvants, transient Treg-cell depletion in mice induced anti-S1 antibodies that neutralized authentic SARS-CoV-2, follicular helper T cell formation and S1-binding germinal center B cell responses, but prevented the onset of developing autoimmune diseases. To further clarify the mechanisms, we investigated maturation of dendritic cells (DCs), which is essential to initiate antigen-specific immunity. We found that the transient Treg-cell depletion resulted in maturation of both migratory and resident DCs in draining lymph nodes that captured S1-antigen. Moreover, we observed S1-specific CD4+T cells and CD8+T cells with interferon-γ production. Thus, captured S1 was successfully presented by DCs, including cross-presentation to CD8+T cells. These data indicate that transient Treg-cell depletion in the absence of adjuvants induces maturation of antigen-presenting DCs and succeeds in generating antigen-specific humoral and cellular immunity against emerging SARS-CoV-2 antigens. Finally, we showed that SARS-CoV-2 antigen-specific immune responses induced by transient Treg-cell depletion in the absence of adjuvants were compatible with those induced with an effective adjuvant, polyriboinosinic:polyribocytidyl acid (poly IC) and that the combination of transient Treg-cell depletion with poly IC induced potent responses. These findings highlight the capacity for manipulating Treg cells to induce protective adaptive immunity to SARS-CoV-2 with activating antigen-presenting DCs, which may improve the efficacy of ongoing vaccine therapies and help enhance responses to emerging SARS-CoV-2 variants.
- 9 December 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (12) , e1010085
Open AccessFoxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens
Regulatory T (Treg) cells, which constitute about 5–10% of CD4+T cells expressing Foxp3 transcription factor and CD25(IL-2 receptor α chain), are key regulators in controlling immunological self-tolerance and various immune responses. However, how Treg cells control antigen-specific immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unclear. In this study, we examined the effect of transient breakdown of the immunological tolerance induced by Treg-cell depletion on adaptive immune responses against administered SARS-CoV-2 antigen, spike protein 1 (S1). Notably, without the use of adjuvants, transient Treg-cell depletion in mice induced anti-S1 antibodies that neutralized authentic SARS-CoV-2, follicular helper T cell formation and S1-binding germinal center B cell responses, but prevented the onset of developing autoimmune diseases. To further clarify the mechanisms, we investigated maturation of dendritic cells (DCs), which is essential to initiate antigen-specific immunity. We found that the transient Treg-cell depletion resulted in maturation of both migratory and resident DCs in draining lymph nodes that captured S1-antigen. Moreover, we observed S1-specific CD4+T cells and CD8+T cells with interferon-γ production. Thus, captured S1 was successfully presented by DCs, including cross-presentation to CD8+T cells. These data indicate that transient Treg-cell depletion in the absence of adjuvants induces maturation of antigen-presenting DCs and succeeds in generating antigen-specific humoral and cellular immunity against emerging SARS-CoV-2 antigens. Finally, we showed that SARS-CoV-2 antigen-specific immune responses induced by transient Treg-cell depletion in the absence of adjuvants were compatible with those induced with an effective adjuvant, polyriboinosinic:polyribocytidyl acid (poly IC) and that the combination of transient Treg-cell depletion with poly IC induced potent responses. These findings highlight the capacity for manipulating Treg cells to induce protective adaptive immunity to SARS-CoV-2 with activating antigen-presenting DCs, which may improve the efficacy of ongoing vaccine therapies and help enhance responses to emerging SARS-CoV-2 variants.
- Open Access
- 19 January 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (2)
JEM career launchpad
JEM has been a launching pad for scientific careers since its inception. Here is a collection of testimonials attesting to the diversity of the scientific community it serves.
- 19 January 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (2)
Open AccessJEM career launchpad
JEM has been a launching pad for scientific careers since its inception. Here is a collection of testimonials attesting to the diversity of the scientific community it serves.
- 7 August 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (34) , 20696-20705
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
Significance: Regulatory T (Treg) cells, expressing CD25 and Foxp3, constitute about 5 to 10% of peripheral CD4+T cells and maintain immunological self-tolerance through the suppression of various immune responses. Here we found that skin Treg cells expanded by UVB exposure possess a unique TCR repertoire and a healing function. UVB-expanded skin Treg (UVB-skin Treg) cells expressed proenkephalin (PENK), an endogenous opioid precursor, and amphiregulin (AREG), the epidermal growth factor receptor ligand. The Treg-derived PENK and AREG promoted keratinocyte outgrowth in a skin explant assay. Moreover, UVB-expanded skin Treg cells played a key role in promoting wound healing in vivo. Our results provide a new implication in developing a therapy using PENK+UVB-skin Treg cells.
- 7 August 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (34) , 20696-20705
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
Significance: Regulatory T (Treg) cells, expressing CD25 and Foxp3, constitute about 5 to 10% of peripheral CD4+T cells and maintain immunological self-tolerance through the suppression of various immune responses. Here we found that skin Treg cells expanded by UVB exposure possess a unique TCR repertoire and a healing function. UVB-expanded skin Treg (UVB-skin Treg) cells expressed proenkephalin (PENK), an endogenous opioid precursor, and amphiregulin (AREG), the epidermal growth factor receptor ligand. The Treg-derived PENK and AREG promoted keratinocyte outgrowth in a skin explant assay. Moreover, UVB-expanded skin Treg cells played a key role in promoting wound healing in vivo. Our results provide a new implication in developing a therapy using PENK+UVB-skin Treg cells.
- 1 June 2019
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 139 (6) , 1329-1338.e7
Hyperglycemia Is Associated with Psoriatic Inflammation in Both Humans and Mice
- 1 June 2019
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 139 (6) , 1329-1338.e7
Hyperglycemia Is Associated with Psoriatic Inflammation in Both Humans and Mice
- 28 November 2018
- Published by Wiley in International Journal of Cancer
- Vol. 144 (11) , 2811-2822
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
FOXP3+ regulatory T (Treg) cells suppress anti‐tumor immunity. The suppression of Treg cells is regulated by cytotoxic T‐lymphocyte‐associated antigen‐4 (CTLA‐4), whose expression on the cell surface is tightly regulated. Here we found that Treg cells expressing abundant CTLA‐4 on the cell surface (surface‐CTLA‐4+ Treg) were expanded in human head and neck cancer tissues. RNA sequencing of surface‐CTLA‐4+ and surface‐CTLA‐4− Treg cells infiltrating human head and neck cancer tissues revealed that surface‐CTLA‐4+ Treg cells have a previously undescribed gene expression profile correlating to cell cycle, cell proliferation, and DNA replication. Moreover, surface‐CTLA‐4+ Treg cells were PD‐1+, actively proliferated and associated with CD45RA− FOXP3high Treg cells with strong suppressive function. Thus, surface‐CTLA‐4+ Treg cells with a proliferative gene expression signature and phenotype are key features of head and neck cancer. Targeting surface‐CTLA‐4+ Treg cells might be new strategies to evoke effective immune responses to head and neck cancer.
- 28 November 2018
- Published by Wiley in International Journal of Cancer
- Vol. 144 (11) , 2811-2822
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
FOXP3+ regulatory T (Treg) cells suppress anti‐tumor immunity. The suppression of Treg cells is regulated by cytotoxic T‐lymphocyte‐associated antigen‐4 (CTLA‐4), whose expression on the cell surface is tightly regulated. Here we found that Treg cells expressing abundant CTLA‐4 on the cell surface (surface‐CTLA‐4+ Treg) were expanded in human head and neck cancer tissues. RNA sequencing of surface‐CTLA‐4+ and surface‐CTLA‐4− Treg cells infiltrating human head and neck cancer tissues revealed that surface‐CTLA‐4+ Treg cells have a previously undescribed gene expression profile correlating to cell cycle, cell proliferation, and DNA replication. Moreover, surface‐CTLA‐4+ Treg cells were PD‐1+, actively proliferated and associated with CD45RA− FOXP3high Treg cells with strong suppressive function. Thus, surface‐CTLA‐4+ Treg cells with a proliferative gene expression signature and phenotype are key features of head and neck cancer. Targeting surface‐CTLA‐4+ Treg cells might be new strategies to evoke effective immune responses to head and neck cancer.
- 1 January 2018
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 200 (1) , 119-129
Ultraviolet B–Induced Maturation of CD11b-Type Langerin− Dendritic Cells Controls the Expansion of Foxp3+ Regulatory T Cells in the Skin
Skin dendritic cells (DCs) are divided into several subsets with distinctive functions. This study shows a previously unappreciated role of dermal CD11b-type Langerin− DCs in maintaining immunological self-tolerance after UVB exposure. After UVB exposure, dermal CD11b-type Langerin− DCs upregulated surface CD86 expression, induced proliferation of Foxp3+ regulatory T (Treg) cells without exogenous Ags, and upregulated a set of genes associated with immunological tolerance. This Treg-expansion activity was significantly hampered by CD80/CD86 blockade in vivo. These results indicate that CD11b-type Langerin− DCs from the UVB-exposed skin are specialized to expand Treg cells in the skin, which suppress autoimmunity.
- 1 January 2018
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 200 (1) , 119-129
Ultraviolet B–Induced Maturation of CD11b-Type Langerin− Dendritic Cells Controls the Expansion of Foxp3+ Regulatory T Cells in the Skin
Skin dendritic cells (DCs) are divided into several subsets with distinctive functions. This study shows a previously unappreciated role of dermal CD11b-type Langerin− DCs in maintaining immunological self-tolerance after UVB exposure. After UVB exposure, dermal CD11b-type Langerin− DCs upregulated surface CD86 expression, induced proliferation of Foxp3+ regulatory T (Treg) cells without exogenous Ags, and upregulated a set of genes associated with immunological tolerance. This Treg-expansion activity was significantly hampered by CD80/CD86 blockade in vivo. These results indicate that CD11b-type Langerin− DCs from the UVB-exposed skin are specialized to expand Treg cells in the skin, which suppress autoimmunity.